Concert Pharma (CNCE) Tops Q2 EPS by 3c

August 9, 2016 8:15 AM EDT
Get Alerts CNCE Hot Sheet
Trade CNCE Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

Concert Pharma (NASDAQ: CNCE) reported Q2 EPS of ($0.60), $0.03 better than the analyst estimate of ($0.63). Revenue for the quarter came in at $71 thousand versus the consensus estimate of $30 thousand.

For earnings history and earnings-related data on Concert Pharma (CNCE) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment